Compounds > clenbuterol

clenbuterol and glycogen

clenbuterol has been researched along with glycogen in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19902 (15.38)18.7374
1990's0 (0.00)18.2507
2000's6 (46.15)29.6817
2010's5 (38.46)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edwards, RH; MacLennan, PA1
Engelhardt, G1
Ding, Z; Fogt, D; Hancock, J; Ivy, JL; Lee, M; Pan, SJ1
Ding, Z; Hunt, DG; Ivy, JL1
Curi, R; Fabrício, VE; Fernandes, LC; Fernandez, R; Folador, A; Gobbo-Bordon, D; Hirabara, SM; Jakobi, S; Moretto, KD; Piffar, PM; Pinto, GJ; Rohn, TV; Tchaikovski, O; Tosta, E1
André, C; Borde, I; Couton, D; Erraji-Benchekroun, L; Gaston, J; Guillet, JG; Postic, C1
Bardsley, RG; Buttery, PJ; Jewell, KK; Parr, T; Ryan, KJ; Sensky, PL1
Cancelliero, KM; Durigan, JL; Polacow, ML; Silva, CA; Vieira, RP1
Bali, DS; Banugaria, SG; Chen, YT; Dai, J; Koeberl, DD; Li, S; Luo, X; McVie-Wylie, A; Sun, B1
Bird, A; Bursac, N; Farah, BL; Koeberl, DD; Li, S; Madden, L; Nance, S; Yen, PM; Young, SP1
Bird, A; Han, SO; Koeberl, D; Li, S1
Han, SO; Koeberl, DD; Li, S1
Bali, D; Bursac, N; Case, LE; Chen, W; Corcoran, DL; Han, SO; Hornik, CP; Huffman, KM; Kishnani, PS; Koeberl, DD; Kraus, WE; Li, Y; Smith, EC; Thurberg, BL; Walters, C1

Trials

2 trial(s) available for clenbuterol and glycogen

ArticleYear
Effect of anabolic agents on calpastatin promoters in porcine skeletal muscle and their responsiveness to cyclic adenosine monophosphate- and calcium-related stimuli.
    Journal of animal science, 2006, Volume: 84, Issue:11

    Topics: Anabolic Agents; Animals; Calcium; Calcium-Binding Proteins; Cell Line; Clenbuterol; Cyclic AMP; Gene Expression Regulation; Glycogen; Muscle, Skeletal; Promoter Regions, Genetic; RNA, Messenger; Swine

2006
Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease.
    Molecular therapy : the journal of the American Society of Gene Therapy, 2018, 09-05, Volume: 26, Issue:9

    Topics: Adult; Aged; Clenbuterol; Double-Blind Method; Female; Glycogen; Glycogen Storage Disease Type II; Humans; Male; Middle Aged; Muscle, Skeletal; Quadriceps Muscle

2018

Other Studies

11 other study(ies) available for clenbuterol and glycogen

ArticleYear
Effects of clenbuterol and propranolol on muscle mass. Evidence that clenbuterol stimulates muscle beta-adrenoceptors to induce hypertrophy.
    The Biochemical journal, 1989, Dec-01, Volume: 264, Issue:2

    Topics: Animals; Body Composition; Clenbuterol; Cyclic AMP; Ethanolamines; Female; Glycogen; Heart; Hypertrophy; Lactates; Liver; Muscle Proteins; Muscles; Myocardium; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Reference Values; RNA

1989
Structure-activity relationships in further series of amino-halogen substituted phenyl-aminoethanols.
    Arzneimittel-Forschung, 1984, Volume: 34, Issue:11A

    Topics: Adrenergic beta-Agonists; Animals; Bronchial Provocation Tests; Bronchodilator Agents; Cats; Clenbuterol; Ethanolamines; Female; Glycogen; Guinea Pigs; Heart Rate; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred Strains; Myocardium; Rats; Rats, Inbred Strains; Structure-Activity Relationship

1984
Effects of clenbuterol on insulin resistance in conscious obese Zucker rats.
    American journal of physiology. Endocrinology and metabolism, 2001, Volume: 280, Issue:4

    Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Clenbuterol; Female; Glucose; Glycogen; Insulin; Insulin Resistance; Muscle, Skeletal; Obesity; Organ Size; Rats; Rats, Zucker; Triglycerides

2001
Clenbuterol prevents epinephrine from antagonizing insulin-stimulated muscle glucose uptake.
    Journal of applied physiology (Bethesda, Md. : 1985), 2002, Volume: 92, Issue:3

    Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Epinephrine; Female; Glucose; Glucose-6-Phosphate; Glycogen; In Vitro Techniques; Insulin; Insulin Receptor Substrate Proteins; Muscle, Skeletal; Osmolar Concentration; Phosphatidylinositol 3-Kinases; Phosphoproteins; Rats; Rats, Sprague-Dawley

2002
Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats.
    Cancer letters, 2003, Nov-25, Volume: 201, Issue:2

    Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Body Weight; Cachexia; Carcinoma 256, Walker; Clenbuterol; Cyclooxygenase Inhibitors; Drug Therapy, Combination; Eating; Energy Intake; Glycogen; Insulin; Kidney; Liver; Muscle, Skeletal; Naproxen; Rats; Rats, Wistar

2003
Overexpression of beta2-adrenergic receptors in mouse liver alters the expression of gluconeogenic and glycolytic enzymes.
    American journal of physiology. Endocrinology and metabolism, 2005, Volume: 288, Issue:4

    Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Blotting, Northern; Clenbuterol; Eating; Glucose-6-Phosphatase; Glycogen; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphoenolpyruvate Carboxykinase (ATP); Propranolol; Pyruvate Kinase; Receptors, Adrenergic, beta-2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger

2005
The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2008, Volume: 41, Issue:12

    Topics: Adrenergic beta-Agonists; Animals; Clenbuterol; Connective Tissue; Glycogen; Immobilization; Male; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Organ Size; Rats; Rats, Wistar; Time Factors

2008
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle.
    Molecular genetics and metabolism, 2011, Volume: 103, Issue:2

    Topics: Adrenergic beta-Agonists; alpha-Glucosidases; Animals; Clenbuterol; Disease Models, Animal; Enzyme Replacement Therapy; Glycogen; Glycogen Storage Disease Type II; Male; Mice; Mice, Knockout; Motor Activity; Muscle, Skeletal; Receptor, IGF Type 2

2011
Adjunctive β2-agonist treatment reduces glycogen independently of receptor-mediated acid α-glucosidase uptake in the limb muscles of mice with Pompe disease.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014, Volume: 28, Issue:5

    Topics: Adrenergic beta-2 Receptor Agonists; alpha-Glucosidases; Animals; Cations; Clenbuterol; Densitometry; Dependovirus; Extremities; Genetic Vectors; Glycogen; Glycogen Storage Disease Type II; HEK293 Cells; Humans; Lysosomes; Mice; Mice, Knockout; Muscle, Skeletal; Receptor, IGF Type 2

2014
Synergistic Efficacy from Gene Therapy with Coreceptor Blockade and a β2-Agonist in Murine Pompe Disease.
    Human gene therapy, 2015, Volume: 26, Issue:11

    Topics: Adrenergic beta-Agonists; alpha-Glucosidases; Animals; Antibodies, Monoclonal; CD4 Antigens; Clenbuterol; Combined Modality Therapy; Dependovirus; Genetic Therapy; Glycogen; Glycogen Storage Disease Type II; Immune Tolerance; Mice; Mice, Knockout; Muscle, Skeletal; Myocytes, Cardiac; Recombinant Proteins

2015
Salmeterol enhances the cardiac response to gene therapy in Pompe disease.
    Molecular genetics and metabolism, 2016, Volume: 118, Issue:1

    Topics: alpha-Glucosidases; Animals; Clenbuterol; Dehydroepiandrosterone; Dependovirus; Disease Models, Animal; Enzyme Replacement Therapy; Genetic Therapy; Genetic Vectors; Glycogen; Glycogen Storage Disease Type II; Humans; Mice; Mice, Knockout; Myocardium; Salmeterol Xinafoate

2016